Tag: University of Cambridge

Olatec Therapeutics set to launch dapansutrile Phase 2 trial in Parkinson’s disease

businessnewstoday- February 20, 2024

Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a  journey to tackle Parkinson's disease, a neurodegenerative disorder ... Read More

NeoGenomics wraps up takeover of liquid biopsy platform company Inivata

businessnewstoday- June 26, 2021

NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company ... Read More